QPP Measure #481
Intravesical Bacillus-Calmette Guerin for Non-muscle Invasive Bladder Cancer
Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging.
Submission Methods: Electronic Health Record
Measure Sets: Urology
The following codes apply for this QPP measure:
HCPCS Codes | |||
| Code | Description | ||
|---|---|---|---|
| M1423 | Optimal care for patients with urologic conditions mips value pathway | ||
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com